What could GLP-1 drugs, known for their powerful weight loss benefits, have to do with oncology? Potentially “everything,” according to Deborah Phippa...

Today, a brief rundown of news involving Takeda Pharmaceutical and Maze Therapeutics, as well as updates from Intercept Pharmaceuticals, Soleno Therap...

Dive Brief: Novo Nordisk on Wednesday announced plans to lay off about 11% of its workforce as competition for top-selling medicines Ozempic and Wegov...

Today, a brief rundown of news involving Kriya Therapeutics and Odyssey Therapeutics, as well as updates from Amgen, Regeneron and Merck & Co. that yo...

Dive Brief: The Food and Drug Administration on Tuesday approved a drug-device combination for bladder cancer that its developer, Johnson & Johnson, c...

LB Pharmaceuticals raised $285 million in an initial public offering on Wednesday, marking the first sizable new stock offering for a young biotechnol...

This compelling four-part podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” brings together world-renowned experts to explore the...

Dive Brief: Novartis on Tuesday said it will pay $1.4 billion to acquire the New York-based biotechnology company Tourmaline Bio and its experimental...

Eli Lilly will give small biotechnology companies a chance to use artificial intelligence models trained on years of the pharmaceutical company’s rese...

British biotechnology company NRG Therapeutics on Monday said it raised £50 million, or about $67 million, to advance its lead experimental medicine f...